# 腹主动脉瘤市场 > 腹主动脉瘤市场研究报告按手术类型（开放腹主动脉瘤修复（AAA修复）、血管内腹主动脉瘤修复（EVAR）、其他手术类型）、按设备类型（支架、支架移植物、气囊扩张支架、其他设备类型）、按应用（小型AAA（5.5cm）、中型AAA（5.5-6.9cm）、大型AAA（7cm）、破裂AAA、其他应用）、按最终用户（医院、外科中心、门诊手术中心、其他最终用户）、按材料（聚酯、聚四氟乙烯（PTFE）、聚对苯二甲酸乙二醇酯（PET）、其他材料）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.13% - **2024:** $ 1.66 Billion - **2025:** $ 1.73 Billion - **2035:** $ 2.59 Billion - **Key Players:** Companies such as Metrdonic (US), Abbott Laboratories (US), Boston Scientific (US), Cook Medical (US), Terumo Corporation (JP), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Cardinal Health (US) are some of the major participants in the market. **Report ID:** MRFR/HC/28402-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** July 28, 2026 **URL:** https://www.marketresearchfuture.com/reports/abdominal-aortic-aneurysm-market-30142 --- ## Market Summary ## **Abdominal Aortic Aneurysm Market Overview** As per MRFR analysis, the Abdominal Aortic Aneurysm Market Size was estimated at 1.66 (USD Billion) in 2024. The Abdominal Aortic Aneurysm Market Industry is expected to grow from 1.73 (USD Billion) in 2025 to 2.49 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.13% during the forecast period (2025 - 2034). ### **Key Abdominal Aortic Aneurysm Market Trends Highlighted** The increasing prevalence of cardiovascular diseases, coupled with the aging population, is fueling the demand for abdominal aortic aneurysm (AAA) treatments. Advancements in endovascular repair techniques, such as fenestrated and branched endograft, are expanding treatment options and improving patient outcomes. The rising adoption of minimally invasive procedures is driving market growth, as they offer reduced recovery time and complications compared to traditional open surgery. Additionally, the availability of advanced imaging technologies, such as computed tomography angiography (CTA), is enhancing the diagnosis and monitoring of AAA, leading to earlier detection and timely intervention. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Abdominal Aortic Aneurysm Market Drivers** ### **Technological Advancements in Diagnosis and Treatment** Advancements in medical imaging techniques, such as computed tomography angiography (CTA) and magnetic resonance imaging (MRI), have significantly improved the accuracy and speed of AAA diagnosis. These technologies allow for detailed visualization of the aorta, enabling physicians to detect and characterize aneurysms more precisely. Additionally, the development of endovascular repair techniques, such as endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR), has revolutionized AAA treatment. These minimally invasive procedures involve inserting a stent graft into the aorta to reinforce the weakened area and prevent rupture. The adoption of these advanced technologies is expected to continue driving the growth of the Abdominal Aortic Aneurysm Market Industry as they improve patient outcomes and reduce the risk of complications. ### Rising Prevalence of Risk Factors The prevalence of risk factors associated with AAA, such as smoking, hypertension, and hyperlipidemia, is on the rise globally. These factors contribute to the weakening of the aortic wall, increasing the likelihood of aneurysm formation. The growing incidence of these risk factors is expected to fuel the demand for AAA screening and treatment, thereby driving market expansion. ### Increasing Awareness and Screening Programs Increased awareness about AAA and the availability of effective screening programs have led to a surge in the number of individuals undergoing screening tests. This has resulted in the early detection and treatment of aneurysms, improving patient outcomes and reducing the risk of rupture. Furthermore, government initiatives and public health campaigns aimed at promoting AAA awareness and screening are expected to contribute to the growth of the Abdominal Aortic Aneurysm Market Industry. ## **Abdominal Aortic Aneurysm Market Segment Insights** ### **Abdominal Aortic Aneurysm Market Procedure Type Insights** The Abdominal Aortic Aneurysm Market is segmented based on procedure type into Open Abdominal Aortic Aneurysm Repair (AAA Repair), Endovascular Abdominal Aortic Aneurysm Repair (EVAR), and Other Procedure Types. Among these, the EVAR segment held the largest market share in 2023, owing to its minimally invasive nature and lower risk of complications compared to open repair. EVAR involves accessing the aneurysm through a small incision in the groin and deploying a stent graft to reinforce the weakened aortic wall. This procedure has gained popularity due to its shorter recovery time, reduced pain, and lower risk of bleeding and infection. The Open AAA Repair segment, on the other hand, is anticipated to witness a steady growth rate during the forecast period. This technique involves making a large incision in the abdomen to directly access and repair the aneurysm. While open repair is considered the traditional approach, it is associated with higher risks of complications and a longer recovery period. However, it remains the preferred option for complex aneurysms or in cases where EVAR is not feasible. Other Procedure Types include laparoscopic and robotic-assisted aneurysm repairs, which are less invasive than open repair but more technically demanding. These techniques offer advantages such as smaller incisions, reduced blood loss, and faster recovery time compared to open repair. As technology advances and surgical expertise improves, the adoption of laparoscopic and robotic-assisted procedures is expected to increase in the future. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Abdominal Aortic Aneurysm Market Device Type Insights** Stents, stent grafts, balloon expandable stents, and other device types are the four main categories of devices used to treat abdominal aortic aneurysms. Stents are small, expandable devices that are inserted into the aorta to reinforce the weakened area and prevent it from rupturing. Stent grafts are similar to stents, but they also have a fabric covering that helps to seal the aneurysm and prevent blood from leaking. Balloon expandable stents are a newer type of stent that is inserted into the aorta and then inflated to expand and reinforce the weakened area. The market growth is attributed to the increasing prevalence of abdominal aortic aneurysms, the growing adoption of minimally invasive endovascular procedures, and the rising demand for advanced medical devices. The stent grafts segment is expected to hold the largest market share during the forecast period. This is due to the high prevalence of abdominal aortic aneurysms in the elderly population, the growing adoption of endovascular procedures, and the increasing availability of advanced stent grafts. The balloon expandable stents segment is expected to grow at a faster rate than the other segments during the forecast period. This is due to the increasing adoption of balloon expandable stents in complex and challenging aortic anatomies, the growing demand for less invasive procedures, and the increasing availability of innovative balloon expandable stents. ### **Abdominal Aortic Aneurysm Market Application Insights** The Application segment of the Abdominal Aortic Aneurysm Market is segmented into Small AAA (5.5cm), Medium AAA (5.5-6.9cm), Large AAA (7cm), Ruptured AAA, and Other Applications. The Small AAA segment held the largest market share in 2023, and it is expected to continue to dominate the market during the forecast period. The growth of this segment can be attributed to the increasing prevalence of small AAA, which is often asymptomatic and goes undetected until it becomes larger or ruptures. The Medium AAA segment is expected to witness significant growth during the forecast period, owing to the increasing adoption of endovascular repair techniques for the treatment of medium-sized AAA. The Large AAA segment is expected to account for a significant share of the market in 2023, and it is expected to continue to grow during the forecast period. The growth of this segment can be attributed to the increasing prevalence of large AAA, which is associated with a higher risk of rupture and mortality. The Ruptured AAA segment is expected to witness moderate growth during the forecast period, owing to the increasing adoption of early detection and treatment strategies for AAA. The Other Applications segment is expected to account for a small share of the market in 2023, and it is expected to continue to grow during the forecast period. The growth of this segment can be attributed to the increasing adoption of new and emerging technologies for the treatment of AAA. ### **Abdominal Aortic Aneurysm Market End User Insights** The Abdominal Aortic Aneurysm Market is segmented based on End Users into Hospitals, Surgical Centers, Ambulatory Surgery Centers, and Other End Users. Among these segments, Hospitals held the largest market share in 2023, accounting for approximately 60% of the Abdominal Aortic Aneurysm Market revenue. The growth of this segment can be attributed to the increasing number of patients undergoing AAA repair procedures in hospitals, as well as the availability of advanced medical facilities and skilled healthcare professionals. Surgical Centers are expected to witness a significant growth rate during the forecast period, owing to the increasing number of minimally invasive AAA repair procedures being performed in these centers. Ambulatory Surgery Centers are also expected to contribute to the growth of the Abdominal Aortic Aneurysm Market, as they offer cost-effective and convenient treatment options for patients. Other End Users, such as clinics and private healthcare providers, are expected to account for a small but growing share of the market. ### **Abdominal Aortic Aneurysm Market Material Insights** The Material segment of the Abdominal Aortic Aneurysm Market is segmented into Polyester, Polytetrafluoroethylene (PTFE), Polyethylene Terephthalate (PET), and Other Materials. Polyester holds the largest share of the market due to its high strength, durability, and biocompatibility. PTFE is a fluoropolymer that is resistant to heat, chemicals, and wear. PET is a thermoplastic polymer that is used in a variety of medical applications. Other materials used in abdominal aortic aneurysm repair include polypropylene, polyurethane, and silicone. ### **Abdominal Aortic Aneurysm Market Regional Insights** The Abdominal Aortic Aneurysm Market is segmented by region into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023, owing to factors such as the high prevalence of AAA, favorable reimbursement policies, and advanced healthcare infrastructure. The European market is expected to witness steady growth due to increasing awareness about AAA, technological advancements, and government initiatives. The APAC market is anticipated to grow at a significant pace, driven by the rising geriatric population, increasing prevalence of cardiovascular diseases, and improving healthcare infrastructure.South America and MEA are also expected to contribute to the overall market growth, albeit at a slower pace. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Abdominal Aortic Aneurysm Market Key Players and Competitive Insights** Major players in the Abdominal Aortic Aneurysm Market are actively engaged in strategic collaborations to strengthen their market presence and expand their product portfolios. For instance, in June 2022, Medtronic plc and Cardiva Medical, Inc. announced a distribution agreement to commercialize the latter's Aorfix device, a sutureless aortic valve. Such partnerships enable companies to leverage complementary strengths and gain access to new markets and technologies. Leading Abdominal Aortic Aneurysm Market players are continuously investing in research and development to introduce innovative products and technologies. This focus on innovation drives technological advancements and improves patient outcomes. For example, in October 2022, Terumo Aortic launched the RelayPro proximal stent graft system, designed to provide a conformable and customized fit for complex aortic anatomies. Ongoing advancements in endovascular repair techniques and materials contribute to the growth of the Abdominal Aortic Aneurysm Market. The Abdominal Aortic Aneurysm Market industry is characterized by a competitive landscape with a mix of established and emerging players. Key industry participants include Medtronic plc, Cook Medical, Terumo Aortic, W. L. Gore Associates, Inc., and Endologix, Inc. These companies hold significant market shares and are actively engaged in product development, clinical trials, and strategic partnerships to maintain their competitive edge. ### **Key Companies in the Abdominal Aortic Aneurysm Market Include** ## **Abdominal Aortic Aneurysm Market Industry Developments** The increasing prevalence of AAA, rising awareness about the condition, and technological advancements in endovascular repair procedures drive market growth. Recent news developments include the FDA approval of Medtronic's Endurant II AAA stent graft system, designed to treat complex aortic anatomies. Additionally, Cook Medical received CE Mark approval for its Zenith Alpha Aortic Stent Graft System, offering a conformable and low-profile design. Current affairs include research focusing on personalized treatment strategies, such as patient-specific computational modeling to optimize endovascular repair outcomes. Collaboration between industry players and research institutions is also on the rise, aiming to develop innovative devices and improve patient care. ## **Abdominal Aortic Aneurysm Market Segmentation Insights** ### **Abdominal Aortic Aneurysm Market Procedure Type Outlook** ### **Abdominal Aortic Aneurysm Market Device Type Outlook** ### **Abdominal Aortic Aneurysm Market Application Outlook** ### **Abdominal Aortic Aneurysm Market End User Outlook** ### **Abdominal Aortic Aneurysm Market Material Outlook** ### **Abdominal Aortic Aneurysm Market Regional Outlook** ## Market Drivers ### Growing Geriatric Population 老年人口的增加是腹主动脉瘤市场的显着驱动力。随着个体年龄的增长，患 AAA 的风险不断增加，使这一人群特别容易受到伤害。世界卫生组织预计，到2050年，60岁及以上的人口数量将增加一倍，这可能导致AAA病例相应增加。   这种人口结构的变化需要加强针对老年人需求的医疗保健服务，包括 AAA 的筛查和治疗。随着医疗保健系统适应不断增长的人口，腹主动脉瘤市场可能会出现大幅增长，反映出对有效管理策略的迫切需要。 - 根据世界银行的数据，全球预期寿命延长至 73 岁以上，导致老年人口稳步增长，需要加强心血管筛查、血管干预和腹主动脉瘤治疗。 ### Rising Healthcare Expenditure 各地区医疗保健支出的增加是腹主动脉瘤市场的重要驱动力。政府和私营部门正在加大对医疗基础设施的投资，其中包括为 AAA 开发先进的诊断和治疗设施。这种趋势在许多国家都很明显，这些国家正在分配医疗保健预算以改善获得优质医疗服务的机会。   因此，患者更有可能得到及时的诊断和干预，从而带来更好的健康结果。对医疗保健不断增长的财务承诺可能会刺激对 AAA 相关产品和服务的需求，从而推动腹主动脉瘤市场向前发展。 - 根据世界银行的数据，全球目前的医疗支出平均约占 GDP 的 9.9%，用于支持对先进血管成像、专业心血管护理和微创腹主动脉瘤治疗基础设施的投资。 ### Enhanced Diagnostic Technologies 诊断技术的发展在塑造腹主动脉瘤市场方面发挥着关键作用。高分辨率超声和计算机断层扫描 (CT) 等先进成像技术提高了 AAA 检测和监测的准确性。这些创新有助于早期诊断，这对于有效治疗和管理病情至关重要。   随着医疗保健提供者越来越多地采用这些技术，在早期阶段识别 AAA 的可能性就会上升，这可能会带来更好的患者治疗效果。因此，对诊断工具和服务的需求预计将增长，进一步推动腹主动脉瘤市场的扩张。 - 据 PubMed 称，高分辨率 CT 血管造影显示腹主动脉瘤诊断的敏感性超过 95%，支持早期检测、准确的治疗计划和改善临床结果。 ### Increasing Incidence of Aneurysms 腹主动脉瘤（AAA）患病率的上升是腹主动脉瘤市场的关键驱动力。人口老龄化和生活方式选择（包括吸烟和肥胖）等因素促成了这一趋势。根据卫生统计数据，AAA 的发病率预计将会增加，特别是在老年人中。这种人口结构的变化需要加强筛查和治疗选择，从而扩大市场。   此外，人们对 AAA 相关风险因素的日益认识导致筛查举措的增加，这可能会进一步提高对医疗干预措施的需求。随着医疗保健系统适应这些变化，腹主动脉瘤市场可能会出现显着增长，以满足对有效管理和治疗解决方案不断增长的需求。 - IHME 表示，人口老龄化和心血管危险因素继续增加主动脉瘤的全球负担，加强对筛查计划、血管内修复技术和长期血管疾病管理的需求。 ### Advancements in Surgical Techniques 手术技术和技术的创新正在改变腹主动脉瘤市场的格局。与传统开放手术相比，血管内动脉瘤修复术 (EVAR) 等微创手术因其恢复时间短、并发症发生率低而受到关注。   这些进步不仅改善了患者的治疗效果，还通过吸引更多患者寻求有效的治疗方案来推动市场增长。新设备和材料的引入，例如先进的覆膜支架，进一步支持了这一趋势。随着医疗保健提供者越来越多地采用这些创新技术，腹主动脉瘤市场即将扩大，反映出手术实践和患者护理的不断发展。 - 据 PubMed 称，在适当选择的患者中，血管内动脉瘤修复 (EVAR) 的围手术期死亡率显着低于开放手术修复，这鼓励更广泛地采用微创 AAA 手术。 ## Future Outlook 腹主动脉瘤市场预计将在2024年至2035年间以4.13%的年均增长率增长，推动因素包括技术进步、发病率增加和意识提升。 **New opportunities:** - 开发用于门诊手术的微创外科设备。 扩展远程医疗服务，以进行远程患者监测和随访。 投资于基于人工智能的诊断工具，以便于早期检测和风险评估。 到2035年，市场预计将实现显著增长，主要受创新和医疗保健可及性提高的推动。 ## Segment Insights ### 按手术类型：腹主动脉瘤腔内修复术 (EVAR)（最大）与开腹腹主动脉瘤修复术（AAA 修复）（增长最快） 在腹主动脉瘤市场中，手术类型的分布揭示了医疗保健提供者和患者的明显偏好。腹主动脉瘤血管内修复术 (EVAR) 已成为最主要的技术，主要是因为与传统手术方法相比，其微创性和恢复时间更快。开放性腹主动脉瘤修复术（AAA Repair）仍然占据 64% 的份额，但它的光芒正日益被 EVAR 的日益普及所掩盖。其他手术类型仍然相关，但不会挑战 EVAR 和 AAA Repair 在市场上保持的主导地位。腹主动脉瘤市场的增长趋势表明，人们正在向微创治疗方案强烈转变。 EVAR 不断获得关注，主要得益于技术进步和患者治疗效果的改善，使其成为许多血管外科医生的首选。相反，开放式 AAA 修复的增长速度正在放缓，尽管它对于 EVAR 不适用的特定情况仍然至关重要。整体市场动态表明，随着越来越多的医疗机构增强其 EVAR 产品，在对治疗腹主动脉瘤的效率和有效性的需求的推动下，该细分市场将继续大幅扩张。 美敦力通过先进的 Endurant 支架移植技术继续扩大其 EVAR 产品组合，加强微创腹主动脉瘤治疗并支持全球血管外科医生更广泛地采用。 ### 按器械类型：覆膜支架（最大）与球囊扩张支架（增长最快） 腹主动脉瘤市场有多种关键器械类型，特别是支架、覆膜支架、球囊扩张支架和其他器械类型。其中，覆膜支架因其在治疗 AAA 方面的卓越性能和有效性而占据最大市场份额，达 58%。支架也保持着重要的地位，而球囊扩张支架由于其在临床实践中的采用迅速增长而成为一大亮点。其他设备类型继续发挥作用，尽管它们对整体市场动态的贡献较小。该细分市场的增长趋势主要受到技术进步和 AAA 治疗意识增强的影响。人口老龄化和相关血管疾病的增加推动了对有效干预设备的需求。此外，制造和设计方面的创新改善了患者的治疗效果并减少了并发症，进一步推动了覆膜支架和球囊扩张支架在临床环境中的采用。 雅培实验室继续投资于血管装置创新和临床研究，支持先进支架技术的开发，以提高手术成功率和长期血管修复效果。 ### 按应用分类：中型 AAA（最大）与破裂 AAA（增长最快） 在腹主动脉瘤市场中，中型 AAA 细分市场（尺寸范围为 5.5 至 6.9 厘米）占据最大的市场份额，为 46%，因为诊断出该尺寸的患者患病率较高。小 AAA（5.5 厘米）和大 AAA（7 厘米）紧随其后，但中 AAA 在治疗重点和医疗程序方面明显占主导地位。破裂的 AAA 也非常重要，代表了重症监护方面，及时干预对于患者的生存至关重要，因此在市场策略中获得了越来越多的认可。 中等 AAA（主导）与破裂 AAA（新兴） 中 AAA 细分市场的特点是其巨大的市场占有率，这主要是由于诊断成像和早期检测技术的预计增长。由于这种尺寸范围内的动脉瘤延迟治疗的影响，该细分市场吸引了医疗保健提供者的极大关注，同时还通过侵入性较小的干预策略显示出良好的结果。另一方面，破裂的 AAA 类别被认为是一个新兴的领域，由于手术技术的进步和对破裂危及生命性质的认识的提高而受到关注。随着治疗效果和患者管理方案的改善，对破裂病例快速反应的重视正在重塑动脉瘤领域的治疗重点。 ### 按最终用户：医院（最大）与门诊手术中心（增长最快） 在腹主动脉瘤市场中，医院在最终用户中保持着最大的份额（69%），这表明医院对能够处理复杂动脉瘤病例的综合医疗系统的高度依赖。手术中心和门诊手术中心也对市场做出了贡献，但其份额相对较小。最终用户的多样性反映了治疗和患者护理方法的不同，医院因其先进的设施和专业的医务人员而成为手术干预的主要选择。 医院（主要）与外科中心（新兴） 医院凭借丰富的资源和配备经验丰富外科医生的专业部门，成为腹主动脉瘤市场的主导者。他们提供全面的护理，包括术前评估、复杂的手术和术后管理，以满足广泛的患者需求。另一方面，外科中心正在成为重要的替代方案，提供简化的服务并通常降低手术成本。虽然手术中心注重效率和缩短恢复时间，但它们可能缺乏医院的广泛设施，这限制了它们处理复杂手术病例的能力。这种对比说明了腹主动脉瘤患者护理环境的不断演变。 ### 按材料分类：聚酯（最大）与聚四氟乙烯 (PTFE)（增长最快） 在腹主动脉瘤市场中，材料领域呈现出多样化的市场份额分布。聚酯由于其耐用性和生物相容性的平衡特性而占据最大份额，达到 55%，使其成为许多医疗专业人员的首选。与此同时，聚四氟乙烯 (PTFE) 正受到越来越多的关注，因为它为外科应用提供了绝佳的选择，特别是在考虑灵活性和耐体液性的情况下。聚酯的主导地位得益于其在市场上的长期存在，而聚四氟乙烯的独特属性正在为快速采用开辟一席之地。目前，材料领域的增长趋势表明正在转向更具创新性的解决方案，特别是随着腹主动脉瘤患病率的上升。对微创手术技术的需求正在推动 PTFE 等材料的使用，这些材料更容易处理并集成到此类手术中。随着技术的进步，我们可以预期市场动态将进一步发展，鼓励使用先进的聚合物来提高患者的治疗效果并减少手术时间，从而以动态的方式影响整体市场的增长。 聚酯（主导）与聚四氟乙烯 (PTFE)（新兴） 由于其优异的机械强度、易用性和经济性，聚酯已成为腹主动脉瘤市场的主导材料，使其成为许多外科医生的首选。其在各种外科应用中的广泛记录使其赢得了医疗保健专业人员的高度信任。相比之下，聚四氟乙烯 (PTFE) 因其卓越的柔韧性、低摩擦力和生物相容性而成为复杂病例的首选材料，这吸引了外科医生寻找可最大限度减少并发症并缩短愈合时间的替代品。随着医疗技术的发展，我们预计特定应用将逐渐转向 PTFE，特别是在腹腔镜手术和需要创新血管修复方法的情况下。 ## Regional Market Share Analysis ### 北美：创新市场领导者 北美在腹主动脉瘤市场规模方面处于领先地位，到 2024 年将占全球收入的 48.19% 以上。该地区的增长受到先进的医疗基础设施、心血管疾病患病率的增加以及支持性监管框架的推动。 - 据 CDC 称，心脏病仍然是美国的首要死因，到 2022 年，心脏病将导致约 702,880 人死亡，这支持了对先进血管诊断和腹主动脉瘤治疗的持续需求。 对微创手术的需求也在上升，进一步推动市场扩张。美国是主要贡献者，美敦力（Medtronic）、雅培实验室（Abbott Laboratories）和波士顿科学公司（Boston Scientific）等主要参与者在竞争格局中处于领先地位。成熟的医疗保健系统和正在进行的研究计划的存在增强了市场的吸引力。此外，对创新技术和以患者为中心的解决方案的关注预计将维持该地区的增长。 - GE HealthCare 每年投资约 10 亿美元用于研发，加强先进的 CT 血管造影和血管成像技术，改善北美地区腹主动脉瘤的早期诊断和手术规划。 ### 欧洲：新兴监管框架 2024年欧洲腹主动脉瘤市场规模估值为2.4亿美元，成为第二大区域市场，占有30%的份额。由于 AAA 意识的增强和手术技术的进步，该地区正在见证增长。监管机构正在积极推广提高患者安全和治疗效果的指南，预计这将进一步推动市场需求。 - 欧洲药品管理局协调 27 个欧盟成员国的药物科学评估，支持及时批准创新的心血管疗法和医疗技术，以提高整个欧洲的腹主动脉瘤治疗标准。 领先的国家包括德国、法国和英国，其中 B. Braun Melsungen AG 和 Terumo Corporation 等主要参与者正在取得重大进展。竞争格局的特点是老牌公司和新兴初创公司混合存在，重点关注创新解决方案。欧洲市场也受益于医疗保健提供者和制造商之间为改善治疗结果而进行的合作努力。 ### 亚太地区：快速增长的市场潜力 亚太地区正在迅速崛起，成为腹主动脉瘤治疗的重要市场，占据全球约 20% 的市场份额。该地区的增长得益于医疗保健支出的增加、心血管疾病意识的提高以及人口老龄化的加剧。日本和中国等国家在这方面处于领先地位，政府采取了支持性举措，旨在提高医疗保健的可及性和质量。 竞争格局正在不断变化，Terumo Corporation 和 Cook Medical 等本地和国际企业都在扩大其影响力。由于对有效和微创治疗方案的需求，对先进医疗技术的需求不断增长。医疗保健提供者和制造商之间的合作也促进了该领域的创新，进一步推动市场增长。 ### 中东和非洲：尚未开发的市场机会 中东和非洲地区在腹主动脉瘤市场中逐渐崛起，目前占据全球约5%的市场份额。这一增长主要是由医疗保健投资的增加、心血管疾病意识的提高以及对先进医疗技术的需求推动的。各国政府正在重点改善医疗保健基础设施，预计这将在未来几年促进市场扩张。 南非和阿联酋等国家处于领先地位，越来越多的医疗机构采用先进的治疗方案。竞争格局的特点是本地和国际参与者的混合，以及创新解决方案的增长机会。该地区独特的挑战，例如不同的医疗保健服务，为市场参与者带来了障碍和机遇。 ## Competitive Benchmarking 腹主动脉瘤市场的特点是竞争格局日益受到创新、战略合作伙伴关系和区域扩张的影响。美敦力（美国）、雅培实验室（美国）和波士顿科学公司（美国）等主要参与者处于领先地位，利用其广泛的研发能力来增强产品供应。美敦力（美国）专注于先进的微创技术，而雅培（美国）则强调整合[数字健康](https://www.marketresearchfuture.com/reports/digital-healthcare-market-7636)解决方案融入他们的设备。波士顿科学公司（美国）似乎正致力于通过战略收购扩大其产品组合，从而增强其市场占有率。总的来说，这些策略营造了一个动态的环境，在这种环境中，竞争不仅基于价格，还基于技术进步和患者结果。在商业策略方面，公司越来越多地实现制造本地化，以降低成本并提高供应链效率。这种方法在区域参与者也发挥影响力的适度分散的市场中尤其重要。竞争结构正在演变，较大的公司寻求通过并购来巩固自己的地位，而较小的实体则专注于利基创新。这种二元性创造了一个复杂的市场格局，其中敏捷性和对市场需求的响应能力至关重要。 八月，美敦力（美国）宣布推出一款专为治疗腹主动脉瘤而设计的新型血管内覆膜支架。该产品有望通过为复杂病例提供更量身定制的解决方案来提高患者的治疗效果。这种创新设备的推出强调了美敦力对推进微创手术选择的承诺，这可能会重塑该领域的治疗方案。 9 月，雅培实验室（美国）宣布与一家领先的远程医疗提供商建立合作伙伴关系，将远程监控功能集成到其动脉瘤管理解决方案中。这一战略举措表明了数字健康整合的更广泛趋势，可以提高患者参与度和实时数据收集。此类举措可以提高治疗计划的整体疗效，并促进更积极主动的患者护理方法。 7 月，波士顿科学公司（美国）完成了对一家专门从事下一代血管手术成像技术的小型公司的收购。此次收购可能会增强波士顿科学公司为腹主动脉瘤治疗提供全面解决方案的能力，从而增强其竞争优势。先进成像技术的集成可以改善手术结果和患者安全，与行业向精准医疗的转变保持一致。 截至十月，腹主动脉瘤市场的竞争趋势越来越多地由数字化、可持续性和人工智能的集成来定义。随着公司认识到协作创新在应对复杂的医疗保健挑战方面的价值，战略联盟变得越来越普遍。展望未来，竞争差异化预计将不断发展，从基于价格的竞争明显转向关注技术创新、供应链可靠性和改善患者治疗效果。这种转变最终可能会重新定义市场成功的参数。 ## Recent News & Developments 腹主动脉瘤（AAA）患病率的不断上升、人们对该病的认识不断提高以及血管内修复手术的技术进步推动了市场的增长。 最近的新闻动态包括 FDA 批准 Medtronic 的 Endurant II AAA 覆膜支架系统，该系统旨在治疗复杂的主动脉解剖结构。此外，Cook Medical 的 Zenith Alpha 主动脉覆膜支架系统还获得了 CE 标志批准，该系统具有舒适且低调的设计。 当前事务包括专注于个性化治疗策略的研究，例如用于优化血管内修复结果的患者特定计算模型。行业参与者和研究机构之间的合作也在不断增加，旨在开发创新设备并改善患者护理。 ## Report Scope | 2024 年市场规模 | 1.66(USD Billion) | | --- | --- | | 2025 年市场规模 | 1.728(USD Billion) | | 2035 年市场规模 | 2.591(USD Billion) | | 复合年增长率 (CAGR) | 4.13% (2025 - 2035) | | 报告范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 史料 | 2019 - 2024 | | 市场预测单位 | USD Billion | | 主要公司简介 | Metrdonic（美国）、Abbott Laboratories（美国）、Boston Scientific（美国）、Cook Medical（美国）、Terumo Corporation（日本）、B. Braun Melsungen AG（德国）、Johnson & Johnson（美国）、Cardinal Health（美国） | | 涵盖的细分市场 | 程序类型、设备类型、应用程序、最终用户、材料、区域 | | 主要市场机会 | 微创手术技术的进步增强了腹主动脉瘤市场的治疗选择。 | | 主要市场动态 | 微创手术的技术进步推动了腹主动脉瘤市场的增长。 | | 覆盖国家 | 北美、欧洲、亚太地区、南美洲、MEA | ## Frequently Asked Questions **Q: 腹主动脉瘤市场的当前估值是多少？** A: 2024年市场估值为16.6亿美元。 **Q: 到2035年，腹主动脉瘤市场的预计市场规模是多少？** A: 预计到2035年，市场将达到25.91亿美元。 **Q: 在预测期内，腹主动脉瘤市场的预期CAGR是多少？** A: 预计市场在2025年至2035年的年均增长率（CAGR）为4.13%。 **Q: 在腹主动脉瘤市场中，哪些公司被视为关键参与者？** A: 主要参与者包括美敦力、雅培、波士顿科学和库克医疗。 **Q: 腹主动脉瘤市场的主要手术类型有哪些？** A: 主要手术类型包括开放式腹主动脉瘤修复和血管内腹主动脉瘤修复。 **Q: 不同程序类型的估值在市场上如何比较？** A: 在2024年，Open AAA Repair 的估值为6.6亿美元，而 EVAR 的估值为8亿美元。 **Q: 腹主动脉瘤市场中流行的设备类型有哪些？** A: 常见的设备类型包括支架、支架移植物和气囊扩张支架。 **Q: 2024年不同设备类型的市场估值是多少？** A: 在2024年，支架移植物的价值为6.6亿美元，而支架的价值为5亿美元。 **Q: 哪些终端用户主导腹主动脉瘤市场？** A: 医院是主要的终端用户，预计在2024年的估值为8.3亿美元。 **Q: 腹主动脉瘤市场的设备中常用哪些材料？** A: 常见材料包括聚酯、聚四氟乙烯（PTFE）和聚对苯二甲酸乙二醇酯（PET）。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/abdominal-aortic-aneurysm-market-30142*